Mounjaro makers to explore solutions to allow weight-loss jab to be publicly funded

Mounjaro has been available to buy privately since earlier this year, with some Irish patients also buying it at a lower cost in Northern Ireland. Picture: Niall Carson/PA

The makers of weight-loss drug Mounjaro have said that they will work with health authorities to “find solutions” after the HSE was advised the jabs are too expensive to approve for public funding.

An assessment found the multi-billion euro cost of giving Mounjaro to everyone eligible is not value for money despite being a very effective treatment for obesity, said the National Centre for Pharmacoeconomics (NCPE).